Ascend Wellness Holdings, Inc.

source: coverage-next-full ticker: AAWH step: 01 title: Business Model Overview date: 2026-06-03

Step 01 — Business Model Overview: Ascend Wellness Holdings (AAWH)

Business Description [S1]

Ascend Wellness Holdings, Inc. is a vertically integrated Multi-State Cannabis Operator (MSO) founded in 2018 and headquartered in Morristown, New Jersey. The company cultivates, manufactures, and retails cannabis products across seven US states through owned dispensaries and a growing wholesale distribution network. [S1: 10-K FY2024 — Business Description]

AAWH operates primarily in limited-license markets — states where the number of cannabis cultivators, processors, and retailers is capped by regulation — which historically supported higher price points and margins than open-license states. As of Q1 2026, AAWH operates 51 retail dispensary locations and sells wholesale cannabis to third-party dispensaries. [S2: Q1 2026 earnings press release]

Value-Chain Layer Map

[S3: 10-K FY2024 — Segment reporting, MD&A]

State Footprint (as of Q1 2026)

[S4: 10-K FY2024 — Properties; press releases Q3–Q4 2024]

Revenue Architecture

Retail vs. Wholesale Split

[S5: 10-K FY2024 disaggregated revenue note; FY2025 estimates from press releases]

Product Portfolio

AAWH launched 566 new SKUs in FY2025, indicating active product development. [S6: FY2025 earnings PR]

Economic Model

Unit economics (retail dispensary):

• Average revenue per location (FY2024): ~$562M ÷ 39 locations ≈ $14.4M/location/year
• Gross margin: 32.8% (FY2024), improving to 38.4% (Q1 2026)
• Adj. EBITDA margin: 20.7% (FY2024), 23.4% (FY2025)
• Key COGS driver: cultivation + processing costs; improving as operational leverage scales

280E structural drag:

• Under IRC §280E, plant-touching cannabis companies cannot deduct ordinary business expenses (SG&A, depreciation, interest) for federal tax purposes. AAWH pays ~$45–51M/year in income taxes despite reporting GAAP net losses. This is the central distortion in GAAP income metrics — EPS and net income are not meaningful for comparability until 280E is resolved. [S7: 10-K FY2024 — Tax footnote]

Customer / Market

Customers: Retail — individual consumers (medical patients + adult-use recreational). Wholesale — licensed dispensary operators in AAWH's states.

Market structure: Limited-license states dominate AAWH's footprint, which creates meaningful barriers to entry for new competitors but also caps TAM growth as license caps are set by regulators. Ohio adult-use (late 2023 legalization) represents the most recent TAM expansion.

Thesis Tracker Update

Step 01 reinforces the core thesis: AAWH is a retail-heavy MSO with a growing wholesale segment, operating in limited-license markets that provide some pricing power. The 280E tax drag is structural and severe — it is the primary distortion in GAAP financials and the central catalyst if resolved. The 71%/29% retail/wholesale mix provides two revenue vectors. Ohio adult-use ramp is the key near-term organic growth driver.

Source Index

source: coverage-next-full ticker: AAWH step: 04 title: Financial Quality & Adversarial Sweep date: 2026-06-03

Step 04 — Financial Quality & Adversarial Research Sweep: Ascend Wellness Holdings (AAWH)

Financial Statement Quality Assessment [S1]

Income Statement Quality

AAWH's GAAP income statement requires significant adjustment to be analytically useful due to IRC §280E. Key adjustments:

Conclusion: Revenue and Gross Profit are clean metrics. Adj. EBITDA is the primary measure of economic performance. Net income/EPS are structurally impaired by 280E and should not be used for valuation or trend analysis.

Balance Sheet Quality

Key balance sheet flag: Stockholders' equity turned negative in Q4 2025. This is primarily a GAAP accounting artifact of 280E — the company has been paying taxes on gross profit for years while reporting net losses, depleting retained earnings. It does not mean the business is economically worthless (assets of $872M vs. liabilities of $948M). However, it does create covenant risk and limits refinancing flexibility.

Cash Flow Quality

FCF compression is concerning — interest expense (~$51M/yr) now exceeds annual FCF ($12M). The company is consuming cash on an economic basis despite positive Adj. EBITDA. If revenue continues to decline without cost reduction, FCF could turn negative in FY2026.

Adversarial Research Sweep [S2]

Note: No earnings transcripts used; adversarial research conducted via web search, SEC filings review, and public records.

Short Interest / Bearish Theses

Primary bear thesis circulating in public forums:

1. Revenue decline is structural, not cyclical. Bear argument: Illinois and Michigan are permanently oversupplied markets; Ohio is now also trending toward over-licensing. Revenue recovery is not assured.
2. Leverage is unsustainable. Net debt of $216M vs. $12M FCF means the company cannot service debt from operations at current trajectory. If FCF turns negative, AAWH may need to raise dilutive equity.
3. Schedule III rescheduling could disappoint. The rescheduling process has been through multiple delays; bears argue 280E elimination may be later than market expects or get tied up in legal challenges.
4. Negative equity creates covenant risk. Senior note covenants may be tested if EBITDA declines further; technical default risk is non-trivial.
5. OTC listing limits institutional ownership. AAWH cannot uplift to Nasdaq/NYSE while cannabis remains federally illegal, keeping a large buyer pool permanently on the sidelines.

Investigations, Lawsuits, Controversies

SEC/Regulatory investigations: No material SEC enforcement actions identified in filings or public records search. [S2: 10-K FY2024 — Legal Proceedings; web search]

Class action lawsuits: No active securities class action lawsuits identified. Historical: AAWH settled routine commercial disputes in 2022–2023 (details in 10-K legal proceedings note; amounts not material).

$17M Arbitration Reserve (FY2025): AAWH disclosed a $17M arbitration reserve in FY2025 related to a commercial dispute. This was resolved in Q1 2026. Not a going-concern event. [S3: Q1 2026 PR — "resolution of $17M arbitration reserve"]

Management turnover: CEO and CFO were both replaced in August 2024 — significant change within 12 months. New CEO: Samuel Brill (previously EVP Strategy). New CFO: Roman Nemchenko (internal promotion from CAO). Leadership transitions create execution risk during a period of industry headwinds. [S4: Governance file]

Auditor change (March 2025): Macias Gini dismissed; WithumSmith+Brown appointed. Auditor changes are a yellow flag; no accounting restatements identified. Withum is a reputable mid-market auditor with cannabis sector expertise. [S5: SEC 8-K — March 2025]

Dual-class share structure: Founders retain super-voting rights through a dual-class structure. CEO Abner Kurtin (chair/co-founder) and co-founder Frank Perullo control significant voting power disproportionate to economic stake. This creates governance risk but is standard in the cannabis sector. [S6: Governance file]

Cannabis-Specific Compliance Risks

Accounting Adjustments for Analysis

The most important adjustments for analyzing AAWH:

1. Remove 280E income tax from all comparative analysis — use Adj. EBITDA, not GAAP net income.
2. Add back non-cash lease expense where relevant (cannabis leases are significant and non-standard).
3. Treat goodwill ($58M) as potentially impaired if any state licenses are lost — goodwill is largely license-acquisition premium.
4. FCF = Operating Cash Flow - Capex is the most reliable near-term cash generation signal.

Thesis Tracker Update

Step 04 confirms the bear case thesis is primarily execution-risk based (revenue decline, leverage) and catalyst-timing based (280E rescheduling delay). The bull case is that the discount (~2.1x EV/EBITDA vs. 4–5x peers) overcompensates for these risks given: (a) debt is refinanced to 2029 with no near-term maturity, (b) $116M Adj. EBITDA provides a real earnings cushion, (c) 280E elimination could add $45–50M in after-tax cash flow. The auditor change and management turnover are yellow flags, not red flags.

Source Index